US FDA flags manufacturing and data integrity lapses at Dabur India plant

Companies issued an FDA Form 483 are generally required to submit corrective action plans addressing the deficiencies identified during inspections.

Representative Image

Credit: Dabur India

Share this Article:

IANS

Author

View Profile

Indo-Asian News Service or IANS is a private Indian news agency

View Profile